TOKYO – WEBWIRE – Friday, December 22, 2023
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, Astellas) announced today that it has completed...
TOKYO and KANAGAWA – WEBWIRE – Monday, July 24, 2023
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, Astellas) and PeptiDream Inc. (TSE:...
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
TOKYO – WEBWIRE – Friday,...